TickerFactsScreenerDevelopers

Inhibrx Biosciences, Inc. (INBX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: -$219.22M2024: -$331.45M2025: -$135.03M-$135.03M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$135.03M+59.3%
2024-$331.45M-51.2%
2023-$219.22M—